Wave Life Sciences Ltd (NASDAQ: WVE) stock closed at $5.10 on 2/27/24 after a major increase of 10.9%. Moreover, exceptionally high trading volume at 300% of normal accompanied the advance. Relative to the market the stock has been strong over the last nine months and has risen 30.4% during the last week.
Current PriceTarget Research Rating
WVE is expected to be a major Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Wave Life Sciences is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment